Influenza and pneumococcal vaccination in Canada and the United States, 1980-1993: what can the two countries learn from each other?
Identifieur interne : 000B93 ( Main/Exploration ); précédent : 000B92; suivant : 000B94Influenza and pneumococcal vaccination in Canada and the United States, 1980-1993: what can the two countries learn from each other?
Auteurs : D S Fedson [États-Unis]Source :
- Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [ 1058-4838 ] ; 1995.
Descripteurs français
- KwdFr :
- MESH :
- immunologie : Streptococcus pneumoniae, Vaccins antibactériens, Vaccins antigrippaux.
- Canada, Facteurs temps, Humains, Vaccination, États-Unis.
- Wicri :
- geographic : Canada, États-Unis.
English descriptors
- KwdEn :
- MESH :
- chemical , immunology : Bacterial Vaccines, Influenza Vaccines.
- geographic : Canada, United States.
- immunology : Streptococcus pneumoniae.
- Humans, Time Factors, Vaccination.
Abstract
This study compares influenza and pneumococcal vaccination in Canada and the United States during the period 1980-1993. In Canada, the annual distribution of influenza vaccine during this period increased from 33 to 146 doses per 1,000 population. Provincial health departments purchased 80%-90% of all doses distributed. In the United States, annual distribution of influenza vaccine ranged from 70 to 102 doses per 1,000 population from 1981 to 1990 but increased to 159 doses per 1,000 population over the next 3 years. Throughout the study period, the distribution of pneumococcal vaccine in the United States greatly exceeded that in Canada. Despite similar recommendations regarding the use of these vaccines in the two countries, vaccination practices have differed. In Canada, success with influenza vaccination but not pneumococcal vaccination appears to reflect active public-sector involvement in programs for vaccine purchase and delivery. In the United States, the recent increase in the use of both influenza and pneumococcal vaccines has occurred in the absence of substantial public-sector involvement and may reflect the entrepreneurial nature of American medical practice.
DOI: 10.1093/clinids/20.5.1371
PubMed: 7620025
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Influenza and pneumococcal vaccination in Canada and the United States, 1980-1993: what can the two countries learn from each other?</title><author><name sortKey="Fedson, D S" sort="Fedson, D S" uniqKey="Fedson D" first="D S" last="Fedson">D S Fedson</name><affiliation wicri:level="1"><nlm:affiliation>Department of Medicine, University of Virginia School of Medicine, Charlottesville, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Medicine, University of Virginia School of Medicine, Charlottesville</wicri:regionArea><wicri:noRegion>Charlottesville</wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="1995">1995</date><idno type="RBID">pubmed:7620025</idno><idno type="pmid">7620025</idno><idno type="doi">10.1093/clinids/20.5.1371</idno><idno type="wicri:Area/Main/Corpus">000B90</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000B90</idno><idno type="wicri:Area/Main/Curation">000B90</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000B90</idno><idno type="wicri:Area/Main/Exploration">000B90</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Influenza and pneumococcal vaccination in Canada and the United States, 1980-1993: what can the two countries learn from each other?</title><author><name sortKey="Fedson, D S" sort="Fedson, D S" uniqKey="Fedson D" first="D S" last="Fedson">D S Fedson</name><affiliation wicri:level="1"><nlm:affiliation>Department of Medicine, University of Virginia School of Medicine, Charlottesville, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Medicine, University of Virginia School of Medicine, Charlottesville</wicri:regionArea><wicri:noRegion>Charlottesville</wicri:noRegion></affiliation></author></analytic><series><title level="j">Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</title><idno type="ISSN">1058-4838</idno><imprint><date when="1995" type="published">1995</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Bacterial Vaccines (immunology)</term><term>Canada (MeSH)</term><term>Humans (MeSH)</term><term>Influenza Vaccines (immunology)</term><term>Streptococcus pneumoniae (immunology)</term><term>Time Factors (MeSH)</term><term>United States (MeSH)</term><term>Vaccination (MeSH)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Canada (MeSH)</term><term>Facteurs temps (MeSH)</term><term>Humains (MeSH)</term><term>Streptococcus pneumoniae (immunologie)</term><term>Vaccination (MeSH)</term><term>Vaccins antibactériens (immunologie)</term><term>Vaccins antigrippaux (immunologie)</term><term>États-Unis (MeSH)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="immunology" xml:lang="en"><term>Bacterial Vaccines</term><term>Influenza Vaccines</term></keywords><keywords scheme="MESH" type="geographic" xml:lang="en"><term>Canada</term><term>United States</term></keywords><keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Streptococcus pneumoniae</term><term>Vaccins antibactériens</term><term>Vaccins antigrippaux</term></keywords><keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Streptococcus pneumoniae</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Humans</term><term>Time Factors</term><term>Vaccination</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Canada</term><term>Facteurs temps</term><term>Humains</term><term>Vaccination</term><term>États-Unis</term></keywords><keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Canada</term><term>États-Unis</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">This study compares influenza and pneumococcal vaccination in Canada and the United States during the period 1980-1993. In Canada, the annual distribution of influenza vaccine during this period increased from 33 to 146 doses per 1,000 population. Provincial health departments purchased 80%-90% of all doses distributed. In the United States, annual distribution of influenza vaccine ranged from 70 to 102 doses per 1,000 population from 1981 to 1990 but increased to 159 doses per 1,000 population over the next 3 years. Throughout the study period, the distribution of pneumococcal vaccine in the United States greatly exceeded that in Canada. Despite similar recommendations regarding the use of these vaccines in the two countries, vaccination practices have differed. In Canada, success with influenza vaccination but not pneumococcal vaccination appears to reflect active public-sector involvement in programs for vaccine purchase and delivery. In the United States, the recent increase in the use of both influenza and pneumococcal vaccines has occurred in the absence of substantial public-sector involvement and may reflect the entrepreneurial nature of American medical practice.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">7620025</PMID><DateCompleted><Year>1995</Year><Month>08</Month><Day>31</Day></DateCompleted><DateRevised><Year>2019</Year><Month>05</Month><Day>12</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">1058-4838</ISSN><JournalIssue CitedMedium="Print"><Volume>20</Volume><Issue>5</Issue><PubDate><Year>1995</Year><Month>May</Month></PubDate></JournalIssue><Title>Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</Title><ISOAbbreviation>Clin. Infect. Dis.</ISOAbbreviation></Journal><ArticleTitle>Influenza and pneumococcal vaccination in Canada and the United States, 1980-1993: what can the two countries learn from each other?</ArticleTitle><Pagination><MedlinePgn>1371-6</MedlinePgn></Pagination><Abstract><AbstractText>This study compares influenza and pneumococcal vaccination in Canada and the United States during the period 1980-1993. In Canada, the annual distribution of influenza vaccine during this period increased from 33 to 146 doses per 1,000 population. Provincial health departments purchased 80%-90% of all doses distributed. In the United States, annual distribution of influenza vaccine ranged from 70 to 102 doses per 1,000 population from 1981 to 1990 but increased to 159 doses per 1,000 population over the next 3 years. Throughout the study period, the distribution of pneumococcal vaccine in the United States greatly exceeded that in Canada. Despite similar recommendations regarding the use of these vaccines in the two countries, vaccination practices have differed. In Canada, success with influenza vaccination but not pneumococcal vaccination appears to reflect active public-sector involvement in programs for vaccine purchase and delivery. In the United States, the recent increase in the use of both influenza and pneumococcal vaccines has occurred in the absence of substantial public-sector involvement and may reflect the entrepreneurial nature of American medical practice.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fedson</LastName><ForeName>D S</ForeName><Initials>DS</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of Virginia School of Medicine, Charlottesville, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>J-R01AG09145</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Clin Infect Dis</MedlineTA><NlmUniqueID>9203213</NlmUniqueID><ISSNLinking>1058-4838</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001428">Bacterial Vaccines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007252">Influenza Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001428" MajorTopicYN="N">Bacterial Vaccines</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002170" MajorTopicYN="N" Type="Geographic">Canada</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007252" MajorTopicYN="N">Influenza Vaccines</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013296" MajorTopicYN="N">Streptococcus pneumoniae</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014611" MajorTopicYN="Y">Vaccination</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1995</Year><Month>5</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1995</Year><Month>5</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1995</Year><Month>5</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">7620025</ArticleId><ArticleId IdType="doi">10.1093/clinids/20.5.1371</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>États-Unis</li></country></list><tree><country name="États-Unis"><noRegion><name sortKey="Fedson, D S" sort="Fedson, D S" uniqKey="Fedson D" first="D S" last="Fedson">D S Fedson</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/GrippeCanadaV4/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000B93 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000B93 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= GrippeCanadaV4
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:7620025
|texte= Influenza and pneumococcal vaccination in Canada and the United States, 1980-1993: what can the two countries learn from each other?
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:7620025" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a GrippeCanadaV4
| This area was generated with Dilib version V0.6.35. |  |